Literature DB >> 684426

Rebound insomnia: a new clinical syndrome.

A Kales, M B Scharf, J D Kales.   

Abstract

Rebound insomnia followed the withdrawal of three benzodiazepine hypnotic drugs, each of which had been administered in a single nightly dose for only short-term periods. The intense worsening of sleep is attributed to the short duration of the action of these drugs. A hypothesis involving benzodiazepine receptors in the brain is proposed in which there is a delay or lag in replacement of endogenous benzodiazepine-like molecules after the abrupt withdrawal of exogenous drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 684426     DOI: 10.1126/science.684426

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  29 in total

1.  Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation.

Authors:  T Roehrs; L Merlotti; F Zorick; T Roth
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.

Authors:  Timothy A Roehrs; S Randall; E Harris; R Maan; T Roth
Journal:  J Psychopharmacol       Date:  2011-10-16       Impact factor: 4.153

Review 3.  Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology.

Authors:  A A Borbély; T Akerstedt; O Benoit; F Holsboer; I Oswald
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

4.  Emerging clinical trends and perspectives on comorbid patterns of mental disorders in research.

Authors:  Giovanni A Fava; Eliana Tossani; Per Bech; Carmen Berrocal; Guy Chouinard; Claudio Csillag; Hans-Ulrich Wittchen; Winfried Rief
Journal:  Int J Methods Psychiatr Res       Date:  2014-01       Impact factor: 4.035

Review 5.  Polysomnographic effects of hypnotic drugs. A review.

Authors:  L Parrino; M G Terzano
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

6.  Dose determinants of rebound insomnia.

Authors:  T A Roehrs; F J Zorick; R M Wittig; T Roth
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

7.  Approaches in the evaluation of hypnotics: studies with triazolam.

Authors:  R P Purpura
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

8.  Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold.

Authors:  C L Spinweber; L C Johnson
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 9.  Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

Review 10.  Rebound insomnia and newer hypnotics.

Authors:  M Lader
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.